Loading...

CLOV CLOVER HEALTH INVESTMENTS CORP Management Changes 8-K Filing

CLVR

CLV

CLOVER HEALTH INVESTMENTS CORP

(CLOV)

2024 8-K

Show Summary

Summary

Investor Meetings

Financial Statements

CEO Presentation

Q3 Financial Results

Class Action Lawsuit

Star Rating Increase

SEC Investigation Closure

Board Appointment

Financial Results Announcement

Litigation Update

Compliance with Nasdaq's mi...

Bylaws Amendment

CMS Star Ratings Increase

Annual Meeting of Stockholders

Announcement of Counterpart...

Delisting Notice

Litigation Update

Financial Results Announcement

Appointment of Interim CFO

Departure of CFO

Exit from ACO REACH Program

Financial Results Announcement

Management Incentive Plan

Financial Results Announcement

Compliance with Nasdaq's mi...

Derivative Lawsuit Settlement

Annual Meeting of Stockholders

Resignation of Officer

Financial Results Announcement

Settlement of Securities Cl...

Delisting Notice

Business Transformation Ini...

Agreement with Board Observer

Financial Results Announcement

Annual Meeting Announcement

Departure of Chief Growth O...

Appointment of CEO

External Links:

Clover Health appointed Thomas L. Tran as a Class II director, increasing the Board size to nine members; he will receive a pro-rated annual retainer and a restricted stock unit award valued at $200,000.

AI Assistant

CLOVER HEALTH INVESTMENTS CORP

2024

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.